GI cancers risk higher among childhood cancer survivors

Study finds high risk of GI cancers among childhood cancer survivors – Survivors of childhood cancers are at an increased risk of another battle with cancer later in life, according to new research published by the Annals of Internal Medicine. Researchers found that childhood cancer survivors develop these malignancies at a rate nearly five times that of the general population.

35 new drugs approved in 2011 in US

FDA: 35 innovative new drugs approved in fiscal year 2011 — Report shows quick approvals of safe and effective medicines occur in the United States before other countries – Over the past 12 months, the U.S. Food and Drug Administration approved 35 new medicines for patients, like two new treatments for hepatitis C; a drug for late-stage prostate cancer; the first new drug for Hodgkin’s lymphoma in 30 years; and the first new drug for lupus in 50 years.

Remicade infliximab approved to treat ulcerative colitis in children

FDA approves Remicade to treat ulcerative colitis in children older than 6 years – The U.S. Food and Drug Administration approved Remicade (infliximab) to treat moderately to severely active ulcerative colitis (UC) in children older than 6 years who have had inadequate response to conventional therapy.

Adcetris approved to treat two types of lymphoma

FDA approves Adcetris to treat two types of lymphoma – The U.S. Food and Drug Administration recently approved Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL).

Breast implants linked to ALCL a rare cancer

FDA review indicates possible association between breast implants and a rare cancer — Agency requesting health care professionals to report confirmed cases – Saline and silicone gel-filled breast implants are linked to anaplastic large cell lymphoma (ALCL), a very rare type of cancer, announced by US Health Agency FDA.

Vitamin D supplements might help lymphoma patients

Mayo Clinic and collaborators find vitamin D levels associated with survival in lymphoma patients – A new study has found that the amount of vitamin D in patients being treated for diffuse large B-cell lymphoma was strongly associated with cancer progression and overall survival.

Cancer mortality declined in Europe

New figures on cancer in Europe show a steady decline in mortality but big variations — Large variations in mortality exist between countries and between men and women – New figures on deaths from cancer in Europe show a steady decline in mortality between the periods 1990-1994 and 2000-2004. Deaths from all cancers in the European Union (EU) between these two periods fell by nine percent in men and eight percent in women, with a large drop among the middle-aged population.

XMRV virus may cause prostate cancer in people

Researchers find first evidence of virus in malignant prostate cells in prostate cancer — XMRV retrovirus is associated with more aggressive tumors of prostate gland. – XMRV (Xenotropic murine leukemia virus-related virus) — a type of virus known to cause leukemia and sarcomas in animals has been found for the first time in malignant human prostate cancer cells.

Stem cell protein LIN28 offers a new cancer target

LIN28, which maintains cell ‘stemness,’ is abundant in advanced cancers and transforms cells to cancerous state – A protein abundant in embryonic stem cells is now shown to be important in cancer, and offers a possible new target for drug development, report researchers from the Stem Cell Program at Children’s Hospital Boston.

GenWay Biotech distributor of AMDL’s DR-70 cancer test in US and Canada

GenWay Biotech obtains exclusive rights to AMDL’s DR-70 cancer test in US and Canada. AMDL Inc. executes two exclusive distribution agreements for cancer test with GenWay Biotech Inc. – GenWay Biotech, Inc., a US-based diagnostic company which specializes in providing protein and antibody solutions, announced its partnership with AMDL, Inc., a US-based pharmaceutical company with major operations in China, regarding the distribution of AMDL’s DR-70 (FDP) cancer test in both the United States and Canada.

Do NOT follow this link or you will be banned from the site!